About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Tennessee | 991 Studies

Clinical Trials Breast CancerTennessee

Breast Cancer Clinical Trials in Tennessee

Find 991 clinical trials for breast cancer near Tennessee. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 501-520 of 991 trials

CompletedCommunity Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast CancerThis is a retrospective medical record abstraction study.NCT00876070·Atlanta, Georgia and 1 other CompletedPaclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00006459·Huntsville, Alabama and 30 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPhase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesThe purpose of this study of MCS110 with PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of the…NCT02807844·Boston, Massachusetts and 19 others

Active not recruitingAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerThis phase II trial studies how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the combination of avelumab with sacituzumab govitecan…NCT03971409·Birmingham, Alabama and 11 others

SuspendedCANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2The purpose of this study is to test the CANscript™ sensitivity assay, which is a new and different assay developed to test the sensitivity of different cancer types to physician…NCT03253575·Gilbert, Arizona and 29 others

RecruitingStudy of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerThis clinical trial is evaluating tucatinib in combination with Doxil in participants with human epidermal growth factor 2 positive (HER2+) locally advanced or metastatic breast…NCT05748834·Columbia, Maryland and 7 others

CompletedThe BEACON Study (Breast Cancer Outcomes With NKTR-102)The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously…NCT01492101·Flagstaff, Arizona and 152 others

CompletedPhase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimThe study will assess the efficacy of LA-EP2006 compared to Neulasta® with respect to the mean duration of severe neutropenia during treatment with myelosuppressive chemotherapy…NCT01516736·Hot Springs, Arkansas and 52 others

CompletedStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerThe primary objective of this study is to assess and compare the efficacy and safety of sacituzumab govitecan-hzi versus treatment of physician's choice (TPC) in participants with…NCT03901339·Avondale, Arizona and 112 others

CompletedAdjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast CancerThe purpose of this study is to compare two combinations of drugs, epirubicin given with a taxane (ET) or epirubicin given with cyclophosphamide (cytoxan) and followed by a taxane…NCT00140075·Mobile, Alabama and 53 others

Active not recruitingPALbociclib CoLlaborative Adjuvant StudyThis is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib to standard adjuvant endocrine…NCT02513394·Mobile, Alabama and 436 others

CompletedA Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma.NCT02614794·Birmingham, Alabama and 175 others

Active not recruitingComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyThis randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast…NCT01901094·Daphne, Alabama and 1245 others

CompletedStudy to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid TumorsThe primary objective of the study is to determine the maximum tolerated dose of andecaliximab monotherapy and to evaluate the safety and tolerability of andecaliximab (formerly…NCT01803282·Birmingham, Alabama and 17 others

CompletedPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous (IV) administration of XmAb808 in combination with pembrolizumab in subjects…NCT05585034·Los Angeles, California and 11 others

CompletedInterleukin-12 in Treating Patients With Metastatic or Recurrent Breast CancerRATIONALE: Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill breast cancer cells.NCT00004893·Birmingham, Alabama and 48 others

CompletedLapatinib and Trastuzumab With or Without Endocrine TherapyWe think that lapatinib will help to shrink your tumor when given prior to the main or primary therapy for the kind of breast cancer you have been diagnosed with.NCT00548184·Birmingham, Alabama and 5 others

CompletedEverolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast CancerThe purpose of this Phase III study was to confirm the value of adding everolimus to weekly paclitaxel and trastuzumab as treatment of HER2-overexpressing metastatic breast cancer.NCT00876395·Mobile, Alabama and 139 others

Active not recruitingA Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsThis clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood.NCT06157892·Tucson, Arizona and 134 others

TerminatedUltra High Field MRI and MRS Techniques in Diagnosing Breast CancerThis pilot clinical trial studies ultra-high field magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques in diagnosing breast cancer.NCT01938651·Nashville, Tennessee

PreviousPage 26 of 50Next

Other Conditions in Tennessee

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma